• Alyamani EJ, Brandt P, Pena JA, Major AM, Fox JG, Suerbaum S, Versalovic J 2007 Helicobacter hepaticus catalase shares surface-predicted epitopes with mammalian catalases. Microbiology 153: 1006-1016. *

• Atanassov C, Pezennec L, d'Alayer J, Grollier G, Picard B, Fauchere JL 2002 Novel antigens of Helicobacter pylori correspond to ulcer-related antibody pattern of sera from infected patients. J. Clin. Microbiol. 40: 547-552. *

• Ballot E, Bruneel A, Labas V, Johanet C 2003 Identification of rat targets of anti-soluble liver antigen autoantibodies by serologic proteome analysis. Clin. Chem. 49: 634-643. *

• Cecere A, Tancredi L, Gattoni A 2002 Primary sclerosing cholangitis. Panminerva Med. 44: 313-323.

• Fox JG, Gorelick PL, Kullberg MC, Ge Z, Dewhirst FE, Ward JM 1999 A novel urease-negative Helicobacter species associated with colitis and typhlitis in IL-10-deficient mice. Infect. Immun. 67: 1757-1762. *

• Jin LH, Kim DW, Eum WS, Yoon CS, Jang SH, Choi HS, Choi SH, Kim YH, Kim SY, Jung MR, Kang TC, Won MH, Lee HY, Kang JH, Kwon OS, Cho SW, Lee KS, Park J, Choi SY 2003 Human liver catalase: cloning, expression and characterization of monoclonal antibodies. Mol. Cells 15: 381-386. *

• Lamhonwah AM, Ackerley CA, Tilups A, Edwards VD, Wanders RJ, Tein I 2005 OCTN3 is a mammalian peroxisomal membrane carnitine transporter. Biochem. Biophys. Res. Commun. 338: 1966-1972. *

• Orth T, Kellner R, Diekmann O, Faust J, Meyer zum Buschenfelde KH, Mayet WJ 1998 Identification and characterization of autoantibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis. Clin. Exp. Immunol. 112: 507-515. *

• Orth T, Neurath M, Schirmacher P, Treichel U, Meyer zum Buschenfelde KH, Mayet W 1999 Anti-neutrophil cytoplasmic antibodies in a rat model of trinitrobenzenesulphonic acid-induced liver injury. Eur. J. Clin. Invest. 29: 929-939.

• Park Y, Capobianco S, Gao X, Falck JR, Dellsperger KC, Zhang C 2008 Role of EDHF in type 2 diabetes-induced endothelial dysfunction. Am. J. Physiol. Heart Circ. Physiol. Sep 12 [Epub ahead of print]. *

• Ramanuja S, Wolf KM, Sadat MA, Mahoney SJ, Dinauer MC, Nelson RP Jr 2005 Newly diagnosed chronic granulomatous disease in a 53-year-old woman with Crohn disease. Ann. Allergy Asthma Immunol. 95: 204-209.

• Roozendaal C, Pogany K, Horst G, Jagt TG, Kleibeuker JH, Nelis GF, Limburg PC, Kallenberg CG 1999 Does analysis of the antigenic specificities of anti-neutrophil cytoplasmic antibodies contribute to their clinical significance in the inflammatory bowel diseases? Scand. J. Gastroenterol. 34: 1123-1131. *

• Roozendaal C, Zhao MH, Horst G, Lockwood CM, Kleibeuker JH, Limburg PC, Nelis GF, Kallenberg CG 1998 Catalase and alpha-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD). Clin. Exp. Immunol. 112: 10-16. *

• Song Z, Marzilli L, Greenlee BM, Chen ES, Silver RF, Askin FB, Teirstein AS, Zhang Y, Cotter RJ, Moller DR 2005 Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J. Exp. Med. 201: 755-767. *

• Suzuki N, Wakasugi M, Nakaya S, Kokubo N, Sato M, Kajiyama H, Takahashi R, Hirata H, Ezure Y, Fukuda Y, Shimoyama T 2002 Catalase, a specific antigen in the feces of human subjects infected with Helicobacter pylori. Clin. Diagn. Lab. Immunol. 9: 784-788. *

• Zima T, Fialova L, Mestek O, Janebova M, Crkovska J, Malbohan I, Stipek S, Mikulikova L, Popov P 2001 Oxidative stress, metabolism of ethanol and alcohol-related diseases. J. Biomed. Sci. 8: 59-70. *

Number of references = 16

www psc-literature.org